RxDoctor Payments Data

Ghulam Chaudhry, MD

Clinical Cardiac Electrophysiology · Burlington, MANPI 1932196938

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.6%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Boston Scientific at 44.4% of the total. 2025 is the largest year on record at $7,982, 2.4 times the $3,289 reported in 2019.

$15,312in general payments, 2019–2025

Across 115 payments — averaging $133.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$7K
  • Biotronik Inc.$4K
  • Medtronic$4K
  • Abbott$682
  • Biosense Webster, Inc.$247
  • Boehringer Ingelheim$25
  • plus $119 from 6 others
$140,104in research payments, 2019–2025

Across 166 payments — averaging $844.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$125K
  • Biotronik Inc.$13K
  • Abbott$2K

What the payments were for

  • Speaking & faculty fees$4,06327%
  • Travel & lodging$4,11227%
  • Food & beverage$7,13847%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,312 in reported general payments places this provider in the 55th percentile of 106 clinical cardiac electrophysiology providers in Massachusetts.

See all clinical cardiac electrophysiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$241,176
Medicare patients
1,061
Services billed
1,788

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban12$18,482
Flecainide Acetate42$2,609
Metoprolol Succinate36$607
Amiodarone Hcl17$491
Warfarin Sodium18$379

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Burlington

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →